Pap test
NEW YORK, August 22 (Praxis Press). The Pap test has dramatically reduced cervical cancer mortality in the United States, but this test's mean sensitivity for cervical abnormalities may be as low as 58% in the general screening setting. Taylor and colleagues constructed a model to compare the costs and health outcomes associated with annual conventional Pap tests and with biennial Pap tests plus speculoscopy (PPS). For hypothetical women studied between ages 18 and 65 years, biennial PPS screeni
The Scientist Staff
Aug 23, 2000
NEW YORK, August 22 (